Literature DB >> 24333304

Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.

Gabriele Calizzani1, Samantha Profili1, Fabio Candura1, Monica Lanzoni2, Stefania Vaglio3, Livia Cannata1, Liviana Catalano1, Rosa Chianese4, Giancarlo M Liumbruno5, Giuliano Grazzini1.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24333304      PMCID： PMC3853989          DOI： 10.2450/2013.018s

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  28 in total

1.  Clinical and organisational aspects of haemophilia care: the patients' view.

Authors:  Gabriele Calizzani; Romano Arcieri
Journal:  Blood Transfus       Date:  2011-09-21       Impact factor: 3.443

2.  Plasma-derived versus recombinant factor VIII concentrates for the treatment of haemophilia A: plasma-derived is better.

Authors:  Pier Mannuccio Mannucci
Journal:  Blood Transfus       Date:  2010-10       Impact factor: 3.443

3.  Plasma-derived versus recombinant Factor VIII concentrates for the treatment of haemophilia A: recombinant is better.

Authors:  Massimo Franchini
Journal:  Blood Transfus       Date:  2010-10       Impact factor: 3.443

Review 4.  Prothrombin complex concentrates in emergency bleeding disorders.

Authors:  George M Rodgers
Journal:  Am J Hematol       Date:  2012-05-31       Impact factor: 10.047

Review 5.  Plasma fractionation issues.

Authors:  Albert Farrugia; Theo Evers; Pierre-Francois Falcou; Thierry Burnouf; Luiz Amorim; Sylvia Thomas
Journal:  Biologicals       Date:  2009-03-16       Impact factor: 1.856

Review 6.  Factor VIII safety: plasma-derived versus recombinant products.

Authors:  Alessandro Gringeri
Journal:  Blood Transfus       Date:  2011-04-12       Impact factor: 3.443

7.  Expert Consensus Statement on achieving self-sufficiency in safe blood and blood products, based on voluntary non-remunerated blood donation (VNRBD).

Authors: 
Journal:  Vox Sang       Date:  2012-06-13       Impact factor: 2.144

8.  Clotting factor concentrate switching and inhibitor development in hemophilia A.

Authors:  Alfonso Iorio; Paolo Puccetti; Mike Makris
Journal:  Blood       Date:  2012-06-12       Impact factor: 22.113

9.  Quality control of recovered plasma for fractionation: an extensive Italian study.

Authors:  Giuliano Grazzini; Giuseppe Rossi; Daniela Rafanelli; Davide Gambelli; Claudio Farina; Filippo Mori; Paolo Zucchelli; Giorgio Marchiori; Antonio Breda; Giancarlo Maria Liumbruno
Journal:  Transfusion       Date:  2008-04-23       Impact factor: 3.157

10.  Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.

Authors:  Claudio Velati; Luisa Romanò; Laura Fomiatti; Lorella Baruffi; Alessandro Remo Zanetti
Journal:  Transfusion       Date:  2008-07-08       Impact factor: 3.157
View more
  7 in total

Review 1.  The demand for polyvalent immunoglobulins in Italy.

Authors:  Fabio Candura; Monica Lanzoni; Gabriele Calizzani; Samantha Profili; Stefania Vaglio; Simonetta Pupella; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 2.  Public expenditure for plasma-derived and recombinant medicinal products in Italy.

Authors:  Monica Lanzoni; Fabio Candura; Gabriele Calizzani; Claudia Biffoli; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 3.  Present and future challenges in the treatment of haemophilia: the patient's perspective.

Authors:  Romano Arcieri; Angelo C Molinari; Stefania Farace; Giuseppe Mazza; Alberto Garnero; Gabriele Calizzani; Paola Giordano; Emily Oliovecchio; Lorenzo Mantovani; Lamberto Manzoli; Paul Giangrande
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

4.  Sustainability of a public system for plasma collection, contract fractionation and plasma-derived medicinal product manufacturing.

Authors:  Giuliano Grazzini; Anna Ceccarelli; Deanna Calteri; Liviana Catalano; Gabriele Calizzani; Americo Cicchetti
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

5.  Plasma-derived medicinal products: demand and clinical use.

Authors:  Giuliano Grazzini; Pier Mannuccio Mannucci; Fabrizio Oleari
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 6.  The growing importance of achieving national self-sufficiency in immunoglobulin in Italy. The emergence of a national imperative.

Authors:  Albert Farrugia; Giuliano Grazzini; Isabella Quinti; Fabio Candura; Samantha Profili; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2019-12-11       Impact factor: 3.443

7.  Use of fresh-frozen plasma in 2012 at the Fondazione Ca' Granda Hospital of Milan: assessment of appropriateness using record linkage techniques applied to data routinely recorded in various hospital information systems.

Authors:  Monica Lanzoni; Barbara Olivero; Andrea Artoni; Maurizio Marconi; Elisabetta Raspollini; Silvana Castaldi
Journal:  Blood Transfus       Date:  2017-06-19       Impact factor: 3.443
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.